Trulieve projects $250M cash flow as uplisting looms

Trulieve projects $250M cash flow as uplisting looms
Cannabis retailer Trulieve Cannabis announced ambitious financial projections during its Q1 2026 earnings call, forecasting at least $250 million in operating cash flow for the year. The company is simultaneously exploring a potential uplisting to a major U.S. exchange, a significant development for the cannabis sector. The earnings discussion revealed multiple catalysts including Schedule III reclassification impacts, expanded DEA registrations, and anticipated tax relief from the removal of the 280E tax provision. These factors collectively position Trulieve to improve profitability and operational efficiency. The potential uplisting represents a watershed moment for cannabis companies seeking mainstream market access.